Form 4 for MRNA Moderna
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-16 · accession 0001127602-22-014932 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-18 | 2022-05-16 | MRNA | Bancel Stephane | CEO, Dir | J - Other | $0.00 | +24.4K | 5.42M | +0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | J | A | 24,411 | $0.00 | 5,415,946 | D | — | — |